tiprankstipranks
pc:res3o

Respondio

Customer Engagement
Respond.io is a customer conversation management platform that helps mid-market B2C businesses consolidate and orchestrate communications across messaging apps, voice, and email. The software integrates channels such as WhatsApp, Instagram, TikTok, and Messenger with CRM systems and leverages native AI agents for lead qualification and sales automation.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$63M
Total Amount Raised$63M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$63M
Latest Funding Amount$63M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jun 17, 2026
Series B
$62.50M
―

Investors

Investor Name
Funding Round
Camber Partners
Series B
Endeavor Catalyst
Series B

Similar Companies

A snapshot of private companies similar to Respondio, helping you discover and navigate related company profiles.
PC:GRADIGradial
PC:DREAMDreamdata
PC:TAPTITaptica
PC:SIROXSiro

Related News and Analysis

Edvisor – Weekly Recap

Edvisor – Weekly Recap

Edvisor is emerging as a key voice in the debate over how higher education should respond to the...
8h ago
EDV1Q
Humanoid – Weekly Recap

Humanoid – Weekly Recap

Humanoid is a London-based humanoid robotics company that this week underscored its rapid rise, including a $152 million...
8h ago
HUM6W
MeshyAI Strengthens Creator Outreach and Enterprise Analytics With Gamescom Event and New Usage Console

MeshyAI Strengthens Creator Outreach and Enterprise Analytics With Gamescom Event and New Usage Console

MeshyAI is an AI-powered 3D content creation platform, and this weekly recap highlights its latest moves to deepen...
8h ago
MES4T
Assail – Weekly Recap

Assail – Weekly Recap

Assail is an autonomous AI offensive security company, and this weekly recap summarizes notable developments for the firm....
8h ago
ASS2L
Ractigen Therapeutics – Weekly Recap

Ractigen Therapeutics – Weekly Recap

Ractigen Therapeutics – a clinical-stage RNA medicines developer – reported a pivotal week marked by regulatory, clinical, and...
8h ago
RACTI
GTCR – Weekly Recap

GTCR – Weekly Recap

GTCR spent the week reshaping its portfolio and expanding its capital offerings, signaling a measured evolution of its...
8h ago
GTCRX
ProphetX Secures $35 Million, Expands B2B Reach and Presses CFTC on Fintech Rules

ProphetX Secures $35 Million, Expands B2B Reach and Presses CFTC on Fintech Rules

ProphetX, a federally regulated sports-native prediction market, had a pivotal week marked by fresh capital, regulatory engagement, and...
8h ago
PRO5V
Aurenar – Weekly Recap

Aurenar – Weekly Recap

Aurenar is a neuromodulation company focused on improving outcomes for intensive care stroke patients, and this weekly summary...
8h ago
AUREN
CORE Biomedicine Deepens Precision Oncology Pipeline With $21 Million Funding Round and Eisai Licensing Deal

CORE Biomedicine Deepens Precision Oncology Pipeline With $21 Million Funding Round and Eisai Licensing Deal

CORE Biomedicine advanced its growth plans this week with fresh funding and a strategic licensing deal that significantly...
8h ago
COREB
ZeroEyes Restructures Leadership and Accelerates AI Investment as K-12 Security Footprint Grows

ZeroEyes Restructures Leadership and Accelerates AI Investment as K-12 Security Footprint Grows

ZeroEyes continued to evolve its business model this week, reshaping its executive ranks and deepening its presence in...
8h ago
ZEROE